The Ida de Pottère-Leupold and Dr. iur. Erik de Pottère Foundation was founded in 1960 by Dr. iur. Erik de Pottère to support cancer research at the University of Zurich. In 2019, the Comprehensive Cancer Center Zurich is happy to announce the first Ida de Pottère-Leupold und Dr. iur. Erik de Pottère Cancer Research Award. The biennal award recognizes doctoral students and early-career scientists and physician-scientists of the Comprehensive Cancer Center Zurich, who have made a significant contribution to basic and/or clinical cancer research. The awards are endowed with CHF 5.000 each. This year’s award presentation took place at the 2019 Scientific Retreat of the Comprehensive Cancer Center Zurich in Emmetten, Switzerland.
Award presentation to Dr. Jonas Schmid (middle left) and Dr. Ewelina Krzywinska (middle right) by Prof. Dr. Anne Müller (left) and Prof. Dr. med. Markus Manz (right) at the 2019 Scientific Retreat of the Comprehensive Cancer Center Zurich
The 2019 Ida de Pottère-Leupold and Dr. iur. Erik de Pottère Cancer Research Award for doctoral students was conferred to Jonas Schmid, PhD, from the Institute of Molecular Cancer Research, UZH. The award recognizes his work: Histone ubiquitination by DNA damage response is required for efficient DNA replication in unperturbed S Phase. The findings promise to reveal the complex cellular apparatus, as well as epigenetic modifications, modulating efficient DNA replication. These studies may significantly help to shed light on mechanisms of genome instability during cellular proliferation and on patient-specific responses to chemotherapeutic treatments interfering with replication
Jonas Schmid performed his fast track PhD (Master & PhD combined) in Cancer Biology in the labs of Prof. Massimo Lopes and Prof. Lorenza Penengo at the Institute of Molecular Cancer Research, University of Zurich, Switzerland. Since September 2018 he is registered as medical student at the University of Fribourg. “While working on my PhD I recognized the necessity of combining molecular expertise with medical competence to bring new and innovative therapies from bench to bedside, which inspired me to take up the study of medicine” says Jonas Schmid.
The 2019 Ida de Pottère-Leupold and Dr. iur. Erik de Pottère Cancer Research Award for scientists / physician-scientists was conferred to Ewelina Krzywinska, PhD, from the Institute of Anatomy, UZH. The award recognizes her work: Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis. Given the emerging importance of adoptive NK cell transfer in clinical routine, these novel findings provide a rationale to consider and target the hypoxic response in NK cells.
“Every year around 14 million people will be diagnosed with cancer and more than 8 million of them will eventually die. I decided to commit myself to cancer research to better diagnose and treat these patients” remarks Ewelina Krzywinska. Since 2015, Ewelina Krzywinska is a postdoctoral fellow under the supervision of Christian Stockmann at the Cardiovascular Research Center in Paris, France and the Institute of Anatomy, University of Zurich, Switzerland. Her studies focus on hypoxic response in Natural Killer cells and the impact on cytotoxicity and vascular remodeling.
Award Ceremony Program
The Ida de Pottère-Leupold and Dr. iur. Erik de Pottère Foundation was founded in 1960 by Dr. iur. Erik de Pottère to support cancer research at the University of Zurich. The de Pottère Fund is managed by a Board of Trustees, which consists of the board of directors of the Cancer Research Center (CRC) Zurich.
Maries van den Broek, Member of the CRC Zurich Board of Directors
Matthias Guckenberger, Member of the CRC Zurich and CCCZ Board of Directors
Markus G. Manz, Member of the CCCZ Board of Directors
Holger Moch, Member of the CRC Zurich Board of Directors
Anne Müller, Chair of the CRC Zurich and member of CCCZ Board of Directors
Rolf Stahel, Chair of the CCCZ Board of Directors
Michael Weller, Member of the CCCZ Board of Directors
Cancer Research Center (CRC) Zurich
+41 44 635 3724